secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2022-06-23T23:59:59+00:00
Accession:  0001493152-22-017614
Event type: leadership
Sentiment:  positive
Materiality: 0.75
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics appoints Kimberly Murphy as President and CEO; base salary $430K, 800K options grant
--------------------------------------------------------------------------------

- Kimberly Murphy appointed President and CEO effective June 23, 2022; base salary $430,000, bonus target 50%, options for 800k shares at $0.295.
- Murphy was previously a board member since 2020; brings 25+ years vaccine industry experience from Merck and GSK.
- CFO Michael Sullivan awarded 250,000 stock options at $0.295 for interim PEO duties.
- Options vest over five tranches starting immediately through June 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315222017614/0001493152-22-017614-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315222017614/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-017614

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer